Clinical Trial Update: An Observational Study to Learn About the Medicine - BEVACIZUMAB BS [Pfizer] in Colorectal Cancer Patients From Japan.

View source ↗

Summary

Pfizer is conducting an observational study in Japan to learn about bevacizumab in colorectal cancer patients; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab BS (bevacizumab)

Snippet

Sponsor: Pfizer | Conditions: Colorectal Cancer | Status: NOT_YET_RECRUITING